Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Demyelinating Diseases

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Demyelinating Diseases in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"In addition, demyelination and axonal damage in brainstem were exacerbated, levels of Th1 cytokines increased, and Th2 cytokines decreased."1.38Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis. ( Augusto, E; Chen, JF; He, JC; Huang, QY; Li, F; Li, ZZ; Wang, XT; Wang, ZW; Yao, SQ; Zheng, RY, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yao, SQ1
Li, ZZ1
Huang, QY1
Li, F1
Wang, ZW1
Augusto, E1
He, JC1
Wang, XT1
Chen, JF1
Zheng, RY1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Demyelinating Diseases

ArticleYear
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
    Journal of neurochemistry, 2012, Volume: 123, Issue:1

    Topics: Adenosine A1 Receptor Antagonists; Animals; Astrocytes; Axons; Brain Injuries; Cell Proliferation; C

2012